Logo image of DTIL

PRECISION BIOSCIENCES INC (DTIL) Stock Fundamental Analysis

USA - NASDAQ:DTIL - US74019P2074 - Common Stock

5.88 USD
+0.03 (+0.51%)
Last: 11/14/2025, 8:00:01 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to DTIL. DTIL was compared to 531 industry peers in the Biotechnology industry. DTIL may be in some trouble as it scores bad on both profitability and health. DTIL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

DTIL had negative earnings in the past year.
DTIL had a negative operating cash flow in the past year.
DTIL had negative earnings in 4 of the past 5 years.
DTIL had a negative operating cash flow in each of the past 5 years.
DTIL Yearly Net Income VS EBIT VS OCF VS FCFDTIL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

DTIL has a worse Return On Assets (-89.40%) than 72.69% of its industry peers.
DTIL has a Return On Equity of -502.60%. This is in the lower half of the industry: DTIL underperforms 77.40% of its industry peers.
Industry RankSector Rank
ROA -89.4%
ROE -502.6%
ROIC N/A
ROA(3y)-26.66%
ROA(5y)-33.41%
ROE(3y)-165.71%
ROE(5y)-155.21%
ROIC(3y)N/A
ROIC(5y)N/A
DTIL Yearly ROA, ROE, ROICDTIL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for DTIL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DTIL Yearly Profit, Operating, Gross MarginsDTIL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

2

2. Health

2.1 Basic Checks

DTIL does not have a ROIC to compare to the WACC, probably because it is not profitable.
DTIL has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, DTIL has more shares outstanding
Compared to 1 year ago, DTIL has a worse debt to assets ratio.
DTIL Yearly Shares OutstandingDTIL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
DTIL Yearly Total Debt VS Total AssetsDTIL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -10.35, we must say that DTIL is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -10.35, DTIL is not doing good in the industry: 73.07% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.35 is on the high side and indicates that DTIL has dependencies on debt financing.
DTIL has a Debt to Equity ratio of 1.35. This is in the lower half of the industry: DTIL underperforms 78.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Altman-Z -10.35
ROIC/WACCN/A
WACC8.79%
DTIL Yearly LT Debt VS Equity VS FCFDTIL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

DTIL has a Current Ratio of 3.45. This indicates that DTIL is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 3.45, DTIL perfoms like the industry average, outperforming 40.11% of the companies in the same industry.
DTIL has a Quick Ratio of 3.45. This indicates that DTIL is financially healthy and has no problem in meeting its short term obligations.
DTIL has a Quick ratio of 3.45. This is comparable to the rest of the industry: DTIL outperforms 42.18% of its industry peers.
Industry RankSector Rank
Current Ratio 3.45
Quick Ratio 3.45
DTIL Yearly Current Assets VS Current LiabilitesDTIL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for DTIL have decreased strongly by -322.11% in the last year.
The Revenue for DTIL has decreased by -99.07% in the past year. This is quite bad
The Revenue has been growing by 25.30% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-322.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.22%
Revenue 1Y (TTM)-99.07%
Revenue growth 3Y-15.91%
Revenue growth 5Y25.3%
Sales Q2Q%-97.74%

3.2 Future

DTIL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 59.21% yearly.
Based on estimates for the next years, DTIL will show a decrease in Revenue. The Revenue will decrease by -6.43% on average per year.
EPS Next Y-3837.2%
EPS Next 2Y-251.8%
EPS Next 3Y-158.6%
EPS Next 5Y59.21%
Revenue Next Year-85.06%
Revenue Next 2Y-40.73%
Revenue Next 3Y-26.85%
Revenue Next 5Y-6.43%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DTIL Yearly Revenue VS EstimatesDTIL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 20M 40M 60M 80M 100M
DTIL Yearly EPS VS EstimatesDTIL Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -20 -40 -60

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DTIL. In the last year negative earnings were reported.
Also next year DTIL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DTIL Price Earnings VS Forward Price EarningsDTIL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DTIL Per share dataDTIL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8

4.3 Compensation for Growth

DTIL's earnings are expected to decrease with -158.60% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-251.8%
EPS Next 3Y-158.6%

More info and screens

0

5. Dividend

5.1 Amount

DTIL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PRECISION BIOSCIENCES INC

NASDAQ:DTIL (11/14/2025, 8:00:01 PM)

5.88

+0.03 (+0.51%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-03 2025-11-03/bmo
Earnings (Next)03-24 2026-03-24/amc
Inst Owners44.24%
Inst Owner Change2.32%
Ins Owners9.03%
Ins Owner Change0.03%
Market Cap69.33M
Revenue(TTM)698.00K
Net Income(TTM)-83.60M
Analysts84.44
Price Target37.06 (530.27%)
Short Float %4.5%
Short Ratio4.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-33.96%
Min EPS beat(2)-34.62%
Max EPS beat(2)-33.29%
EPS beat(4)0
Avg EPS beat(4)-26.25%
Min EPS beat(4)-34.62%
Max EPS beat(4)-10.86%
EPS beat(8)2
Avg EPS beat(8)34.02%
EPS beat(12)5
Avg EPS beat(12)30.59%
EPS beat(16)7
Avg EPS beat(16)24.06%
Revenue beat(2)0
Avg Revenue beat(2)-99.74%
Min Revenue beat(2)-99.76%
Max Revenue beat(2)-99.72%
Revenue beat(4)0
Avg Revenue beat(4)-96.07%
Min Revenue beat(4)-99.76%
Max Revenue beat(4)-85.37%
Revenue beat(8)2
Avg Revenue beat(8)14.83%
Revenue beat(12)6
Avg Revenue beat(12)39.13%
Revenue beat(16)7
Avg Revenue beat(16)24.26%
PT rev (1m)0%
PT rev (3m)68.99%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.07%
EPS NY rev (1m)0%
EPS NY rev (3m)12.36%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-42.14%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 99.32
P/FCF N/A
P/OCF N/A
P/B 4.17
P/tB 4.43
EV/EBITDA N/A
EPS(TTM)-8.4
EYN/A
EPS(NY)-1.86
Fwd EYN/A
FCF(TTM)-6.25
FCFYN/A
OCF(TTM)-6.22
OCFYN/A
SpS0.06
BVpS1.41
TBVpS1.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -89.4%
ROE -502.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-26.66%
ROA(5y)-33.41%
ROE(3y)-165.71%
ROE(5y)-155.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 27.14%
Cap/Sales 61.32%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.45
Quick Ratio 3.45
Altman-Z -10.35
F-Score1
WACC8.79%
ROIC/WACCN/A
Cap/Depr(3y)28.02%
Cap/Depr(5y)41.2%
Cap/Sales(3y)6.1%
Cap/Sales(5y)8.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-322.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.22%
EPS Next Y-3837.2%
EPS Next 2Y-251.8%
EPS Next 3Y-158.6%
EPS Next 5Y59.21%
Revenue 1Y (TTM)-99.07%
Revenue growth 3Y-15.91%
Revenue growth 5Y25.3%
Sales Q2Q%-97.74%
Revenue Next Year-85.06%
Revenue Next 2Y-40.73%
Revenue Next 3Y-26.85%
Revenue Next 5Y-6.43%
EBIT growth 1Y-452.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-225.53%
EBIT Next 3Y7.12%
EBIT Next 5Y-5.09%
FCF growth 1Y26.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y24.87%
OCF growth 3YN/A
OCF growth 5YN/A

PRECISION BIOSCIENCES INC / DTIL FAQ

Can you provide the ChartMill fundamental rating for PRECISION BIOSCIENCES INC?

ChartMill assigns a fundamental rating of 1 / 10 to DTIL.


What is the valuation status for DTIL stock?

ChartMill assigns a valuation rating of 0 / 10 to PRECISION BIOSCIENCES INC (DTIL). This can be considered as Overvalued.


How profitable is PRECISION BIOSCIENCES INC (DTIL) stock?

PRECISION BIOSCIENCES INC (DTIL) has a profitability rating of 0 / 10.


Can you provide the dividend sustainability for DTIL stock?

The dividend rating of PRECISION BIOSCIENCES INC (DTIL) is 0 / 10 and the dividend payout ratio is 0%.